You just read:

Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI™ (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease

News provided by

Theravance Biopharma, Inc. , Mylan N.V.

Nov 09, 2018, 15:13 ET